132 related articles for article (PubMed ID: 9840738)
1. Highly sensitive hepatitis B surface antigen detection by measuring stable nitroxide radical formation with ESR spectroscopy.
Matsuo T; Shinzawa H; Togashi H; Aoki M; Sugahara K; Saito K; Saito T; Takahashi T; Yamaguchi I; Aoyama M; Kamada H
Free Radic Biol Med; 1998 Nov; 25(8):929-35. PubMed ID: 9840738
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of a highly sensitive enzyme immunoassay of hepatitis B surface antigen using a novel electron spin resonance technique.
Aoki M; Saito T; Watanabe H; Matsuo T; Saito K; Togashi H; Kawata S; Ishikawa K; Aoyama M; Kamada H; Shinzawa H
J Med Virol; 2002 Feb; 66(2):166-70. PubMed ID: 11782924
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
4. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
5. Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis B serologic markers.
Douglas DD; Taswell HF; Rakela J; Rabe D
Transfusion; 1993 Mar; 33(3):212-6. PubMed ID: 8438221
[TBL] [Abstract][Full Text] [Related]
6. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
Martin LA; Stramer SL; Kuhns MC; Schlauder GG
Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
[TBL] [Abstract][Full Text] [Related]
7. The reliability of HBV core antibody in serological screening for hepatitis B virus.
Ba Alawi F; Robertson PW; LePage AK; Jayamaha J; Baleriola C; Rawlinson WD
Pathology; 2013 Aug; 45(5):501-5. PubMed ID: 23842045
[TBL] [Abstract][Full Text] [Related]
8. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
9. [Quantitative analysis of HBV DNA amplified products with microtiter hybridization].
Zhang Q; Ding JJ; Miao XH
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):39-41. PubMed ID: 12870016
[TBL] [Abstract][Full Text] [Related]
10. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor.
Datta S; Banerjee A; Chandra PK; Chakraborty S; Basu SK; Chakravarty R
J Clin Virol; 2007 Nov; 40(3):255-8. PubMed ID: 17869170
[TBL] [Abstract][Full Text] [Related]
11. [Nested polymerase chain reaction (PCR) and multiple cloned antibody capture PCR for the examination of serum hepatitis B virus DNA in negative hepatitis B surface antigen patients suffering from liver diseases].
He J; Wu J; Du S
Zhonghua Nei Ke Za Zhi; 1996 Aug; 35(8):537-41. PubMed ID: 9594146
[TBL] [Abstract][Full Text] [Related]
12. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid amplification technology for hepatitis B virus, and its role in blood donation screening in blood banks.
Bamaga MS; Azahar EI; Al-Ghamdi AK; Alenzi FQ; Farahat FM
Saudi Med J; 2009 Nov; 30(11):1416-21. PubMed ID: 19882053
[TBL] [Abstract][Full Text] [Related]
14. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.
Jongerius JM; Wester M; Cuypers HT; van Oostendorp WR; Lelie PN; van der Poel CL; van Leeuwen EF
Transfusion; 1998 Jan; 38(1):56-9. PubMed ID: 9482395
[TBL] [Abstract][Full Text] [Related]
15. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
16. Clinical trial and performance evaluation of the Wantai HBsAg (CMIA) diagnostic kit for screening blood donors in China.
Chen J; Wang F; Li J; Zuo Q; Wu D; Xiao C
Sci Rep; 2024 Feb; 14(1):1891. PubMed ID: 38307913
[TBL] [Abstract][Full Text] [Related]
17. The biological meaning of anti-HBC positive result in blood donors: relation to HBV-DNA and to other serological markers.
Arraes LC; Ximenes R; Andrieu JM; Lu W; Barreto S; Pereira LM; Castelo A
Rev Inst Med Trop Sao Paulo; 2003; 45(3):137-40. PubMed ID: 12870062
[TBL] [Abstract][Full Text] [Related]
18. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
19. Assay of hepatitis B virus DNA by polymerase chain reaction and its relationship to pre-S- and S-encoded viral surface antigens.
Gerken G; Paterlini P; Manns M; Housset C; Terre S; Dienes HP; Hess G; Gerlich WH; Berthelot P; Meyer zum Büschenfelde KH
Hepatology; 1991 Jan; 13(1):158-66. PubMed ID: 1988337
[TBL] [Abstract][Full Text] [Related]
20. Detection of HBV DNA by nested-PCR in a HBsAg and anti-HBc negative blood bank donor.
Almeida RP; Cardoso DD
J Clin Virol; 2006 Jul; 36(3):231-4. PubMed ID: 16574475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
